Hyperthermia after the use of sublingual misoprostol in the management of uterine atony
Keywords:
Misoprostol, hyperthermia, postpartum hemorrhage.Abstract
Abstract
Hyperthermia secondary to the use of sublingual misoprostol is reported in the literature; in some cases, it requires management in intensive care units. We present the case of a patient with postpartum hemorrhage due to uterine atony, who receives an 800 micrograms dose of sublingual misoprostol, subsequently presenting hyperpyrexia, as part of her clinical evolution and management. Currently, the International Federation of Gynecology and Obstetrics recommends an 800 micrograms sublingual dose schedule. A patient with hyperthermia associated with the use of sublingual misoprostol is presented, with good clinical evolution.
3061
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2020 Ronald Edgardo López Guevara
This work is licensed under a Creative Commons Attribution 4.0 International License.
Privacy statement:
Alerta articles are published under license Creative Commons 4.0 CC BY: https://creativecommons.org/licenses/by/4.0/
Authorship rights
Revista Alerta gives the authors exclusive control of their work and the right to be acknowledged and cited.
